Quintrio
Home

Stock overview

Biodexa Pharmaceuticals plc American Depositary Shs

BDRX

Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.

Last trade $0.00
Day change $0.00 (0.00%)
Day range $2.16 – $2.32
Volume 2,720
Market cap $1M

Open XNAS

Fundamentals

Key company ratios and reported financial statements.

Source: Massive.com

Key ratios

No ratio data was found for BDRX.

Financial statements

Income and cash flow amounts are for the period; balance sheets are point-in-time snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are displayed when available.

No quarterly income statement data was found for BDRX.

Recent news

Company coverage with links to the original publishers.

Publication times in UTC
GlobeNewswire Inc.

ADR Ratio Change

Biodexa Pharmaceuticals announced a 1-for-5 reverse ADR split, effective April 6, 2026, to bring its ADR price into compliance with Nasdaq's $1.00 minimum bid price requirement. The ratio change will convert every 5 old ADRs into 1 new ADR, with fractional shares sold and proceeds distributed to holders.

Dividends

Declared distributions and recorded event dates. Forecasts are not shown.

Updated daily

No declared upcoming dividend found.

No prior dividend records found.

Stock splits

Historical share-structure events and their execution dates.

Updated daily
Execution dateSplit ratioEvent type
Oct 26, 20261-for-8reverse split
Apr 6, 20261-for-5reverse split
Jul 31, 20251-for-10reverse split
Oct 4, 20241-for-25reverse split
Jul 5, 20231-for-80reverse split
Mar 27, 20231-for-4reverse split
Sep 26, 20221-for-5reverse split
Mar 3, 20201-for-5reverse split